 | • レポートコード：QYR9ST03306 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、119ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートでは、世界のmTOR阻害剤市場について調査・分析し、以下の構成でお届け致します。mTOR阻害剤の種類別には、ラパミューン、トリセル、アフィニトール、ゾーレスに、用途別には、腫瘍治療、腎臓移植、その他に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査販売 ・エグゼクティブ・サマリー ・企業別mTOR阻害剤売上データ ・地域別mTOR阻害剤市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ、その他 ・種類別mTOR阻害剤市場規模：ラパミューン、トリセル、アフィニトール、ゾーレス ・用途別mTOR阻害剤市場規模：腫瘍治療、腎臓移植、その他 ・主要メーカーの企業情報：LC Laboratories、Teva Pharmaceutical Industries Ltd.、Exelixis、Novartis Oncology、Pfizer、GSK ・mTOR阻害剤の市場規模予測 ・バリューチェーン及び販売チャネル分析 ・市場機会・課題・リスク・影響因子分析 ... |
mTOR inhibitors are a class of drugs that inhibit the mechanistic target of rapamycin (mTOR).Mammalian target of rapamycin (mTOR) inhibitors block the activity of the mammalian target of rapamycin. Mammalian target of rapamycin is a protein kinase, which regulates growth factors that stimulate cell growth and angiogenesis. In certain cancers the mTOR pathway is more active.
The global mTOR Inhibitors market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the mTOR Inhibitors market based on company, product type, end user and key regions.
This report studies the global market size of mTOR Inhibitors in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of mTOR Inhibitors in these regions.
This research report categorizes the global mTOR Inhibitors market by top players/brands, region, type and end user. This report also studies the global mTOR Inhibitors market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
LC Laboratories
Teva Pharmaceutical Industries Ltd.
Exelixis
Novartis Oncology
Pfizer
GSK
Market size by Product
Rapamune
Torisel
Afinitor
Zortress
Market size by End User
Tumor Treatment
Kidney Transplant
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global mTOR Inhibitors market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of mTOR Inhibitors market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global mTOR Inhibitors companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of mTOR Inhibitors submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of mTOR Inhibitors are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of mTOR Inhibitors market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
レポート目次Table of Contents
1 Study Coverage
1.1 mTOR Inhibitors Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global mTOR Inhibitors Market Size Growth Rate by Product
1.4.2 Rapamune
1.4.3 Torisel
1.4.4 Afinitor
1.4.5 Zortress
1.5 Market by End User
1.5.1 Global mTOR Inhibitors Market Size Growth Rate by End User
1.5.2 Tumor Treatment
1.5.3 Kidney Transplant
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global mTOR Inhibitors Market Size
2.1.1 Global mTOR Inhibitors Revenue 2014-2025
2.1.2 Global mTOR Inhibitors Sales 2014-2025
2.2 mTOR Inhibitors Growth Rate by Regions
2.2.1 Global mTOR Inhibitors Sales by Regions
2.2.2 Global mTOR Inhibitors Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 mTOR Inhibitors Sales by Manufacturers
3.1.1 mTOR Inhibitors Sales by Manufacturers
3.1.2 mTOR Inhibitors Sales Market Share by Manufacturers
3.1.3 Global mTOR Inhibitors Market Concentration Ratio (CR5 and HHI)
3.2 mTOR Inhibitors Revenue by Manufacturers
3.2.1 mTOR Inhibitors Revenue by Manufacturers (2014-2019)
3.2.2 mTOR Inhibitors Revenue Share by Manufacturers (2014-2019)
3.3 mTOR Inhibitors Price by Manufacturers
3.4 mTOR Inhibitors Manufacturing Base Distribution, Product Types
3.4.1 mTOR Inhibitors Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers mTOR Inhibitors Product Type
3.4.3 Date of International Manufacturers Enter into mTOR Inhibitors Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global mTOR Inhibitors Sales by Product
4.2 Global mTOR Inhibitors Revenue by Product
4.3 mTOR Inhibitors Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global mTOR Inhibitors Breakdown Data by End User
6 North America
6.1 North America mTOR Inhibitors by Countries
6.1.1 North America mTOR Inhibitors Sales by Countries
6.1.2 North America mTOR Inhibitors Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America mTOR Inhibitors by Product
6.3 North America mTOR Inhibitors by End User
7 Europe
7.1 Europe mTOR Inhibitors by Countries
7.1.1 Europe mTOR Inhibitors Sales by Countries
7.1.2 Europe mTOR Inhibitors Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe mTOR Inhibitors by Product
7.3 Europe mTOR Inhibitors by End User
8 Asia Pacific
8.1 Asia Pacific mTOR Inhibitors by Countries
8.1.1 Asia Pacific mTOR Inhibitors Sales by Countries
8.1.2 Asia Pacific mTOR Inhibitors Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific mTOR Inhibitors by Product
8.3 Asia Pacific mTOR Inhibitors by End User
9 Central & South America
9.1 Central & South America mTOR Inhibitors by Countries
9.1.1 Central & South America mTOR Inhibitors Sales by Countries
9.1.2 Central & South America mTOR Inhibitors Revenue by Countries
9.1.3 Brazil
9.2 Central & South America mTOR Inhibitors by Product
9.3 Central & South America mTOR Inhibitors by End User
10 Middle East and Africa
10.1 Middle East and Africa mTOR Inhibitors by Countries
10.1.1 Middle East and Africa mTOR Inhibitors Sales by Countries
10.1.2 Middle East and Africa mTOR Inhibitors Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa mTOR Inhibitors by Product
10.3 Middle East and Africa mTOR Inhibitors by End User
11 Company Profiles
11.1 LC Laboratories
11.1.1 LC Laboratories Company Details
11.1.2 Company Business Overview
11.1.3 LC Laboratories mTOR Inhibitors Sales, Revenue and Gross Margin (2014-2019)
11.1.4 LC Laboratories mTOR Inhibitors Products Offered
11.1.5 LC Laboratories Recent Development
11.2 Teva Pharmaceutical Industries Ltd.
11.2.1 Teva Pharmaceutical Industries Ltd. Company Details
11.2.2 Company Business Overview
11.2.3 Teva Pharmaceutical Industries Ltd. mTOR Inhibitors Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Teva Pharmaceutical Industries Ltd. mTOR Inhibitors Products Offered
11.2.5 Teva Pharmaceutical Industries Ltd. Recent Development
11.3 Exelixis
11.3.1 Exelixis Company Details
11.3.2 Company Business Overview
11.3.3 Exelixis mTOR Inhibitors Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Exelixis mTOR Inhibitors Products Offered
11.3.5 Exelixis Recent Development
11.4 Novartis Oncology
11.4.1 Novartis Oncology Company Details
11.4.2 Company Business Overview
11.4.3 Novartis Oncology mTOR Inhibitors Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Novartis Oncology mTOR Inhibitors Products Offered
11.4.5 Novartis Oncology Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Company Business Overview
11.5.3 Pfizer mTOR Inhibitors Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Pfizer mTOR Inhibitors Products Offered
11.5.5 Pfizer Recent Development
11.6 GSK
11.6.1 GSK Company Details
11.6.2 Company Business Overview
11.6.3 GSK mTOR Inhibitors Sales, Revenue and Gross Margin (2014-2019)
11.6.4 GSK mTOR Inhibitors Products Offered
11.6.5 GSK Recent Development
12 Future Forecast
12.1 mTOR Inhibitors Market Forecast by Regions
12.1.1 Global mTOR Inhibitors Sales Forecast by Regions 2019-2025
12.1.2 Global mTOR Inhibitors Revenue Forecast by Regions 2019-2025
12.2 mTOR Inhibitors Market Forecast by Product
12.2.1 Global mTOR Inhibitors Sales Forecast by Product 2019-2025
12.2.2 Global mTOR Inhibitors Revenue Forecast by Product 2019-2025
12.3 mTOR Inhibitors Market Forecast by End User
12.4 North America mTOR Inhibitors Forecast
12.5 Europe mTOR Inhibitors Forecast
12.6 Asia Pacific mTOR Inhibitors Forecast
12.7 Central & South America mTOR Inhibitors Forecast
12.8 Middle East and Africa mTOR Inhibitors Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 mTOR Inhibitors Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Figure mTOR Inhibitors Product Picture
Table mTOR Inhibitors Market Segments
Table Key Manufacturers mTOR Inhibitors Covered
Table Global mTOR Inhibitors Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global mTOR Inhibitors Sales Market Share by Product 2014-2025
Figure Rapamune Product Picture
Table Major Manufacturers of Rapamune
Figure Torisel Product Picture
Table Major Manufacturers of Torisel
Figure Afinitor Product Picture
Table Major Manufacturers of Afinitor
Figure Zortress Product Picture
Table Major Manufacturers of Zortress
Table Global mTOR Inhibitors Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Tumor Treatment
Figure Kidney Transplant
Figure Others
Figure mTOR Inhibitors Report Years Considered
Figure Global mTOR Inhibitors Market Size 2014-2025 (Million US$)
Figure Global mTOR Inhibitors Sales 2014-2025 (K Units)
Table Global mTOR Inhibitors Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global mTOR Inhibitors Sales by Regions 2014-2019 (K Units)
Table Global mTOR Inhibitors Sales Market Share by Regions 2014-2019
Figure Global mTOR Inhibitors Sales Market Share by Regions 2014-2019
Figure 2018 Global mTOR Inhibitors Sales Market Share by Regions
Table Global mTOR Inhibitors Revenue by Regions 2014-2019 (Million US$)
Table Global mTOR Inhibitors Revenue Market Share by Regions 2014-2019
Figure Global mTOR Inhibitors Revenue Market Share by Regions 2014-2019
Figure 2018 Global mTOR Inhibitors Revenue Market Share by Regions
Table Global mTOR Inhibitors Sales by Manufacturers (2014-2019) (K Units)
Table Global mTOR Inhibitors Sales Share by Manufacturers (2014-2019)
Figure Global mTOR Inhibitors Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table mTOR Inhibitors Revenue by Manufacturers (2014-2019) (Million USD)
Table mTOR Inhibitors Revenue Share by Manufacturers (2014-2019)
Figure mTOR Inhibitors Value Share by Manufacturers in 2018
Table Key Manufacturers mTOR Inhibitors Price (2014-2019) (USD/Unit)
Table mTOR Inhibitors Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers mTOR Inhibitors Product Type
Table Date of International Manufacturers Enter into mTOR Inhibitors Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global mTOR Inhibitors Sales by Product (2014-2019) (K Units)
Table Global mTOR Inhibitors Sales Share by Product (2014-2019)
Figure Global mTOR Inhibitors Sales Market Share by Product (2014-2019)
Figure Global mTOR Inhibitors Sales Market Share by Product in 2018
Table Global mTOR Inhibitors Revenue by Product (2014-2019) (Million US$)
Table Global mTOR Inhibitors Revenue Share by Product (2014-2019)
Figure Global mTOR Inhibitors Revenue Market Share by Product (2014-2019)
Figure Global mTOR Inhibitors Revenue Market Share by Product in 2018
Table mTOR Inhibitors Price by Product 2014-2019 (USD/Unit)
Table Global mTOR Inhibitors Sales by End User (2014-2019) (K Units)
Table Global mTOR Inhibitors Sales Share by End User (2014-2019)
Figure Global Sales mTOR Inhibitors Market Share by End User (2014-2019)
Figure Global Sales mTOR Inhibitors Market Share by End User in 2018
Figure North America mTOR Inhibitors Sales Growth Rate 2014-2019 (K Units)
Figure North America mTOR Inhibitors Revenue Growth Rate 2014-2019 (Million US$)
Table North America mTOR Inhibitors Sales by Countries (2014-2019) (K Units)
Table North America mTOR Inhibitors Sales Market Share by Countries (2014-2019)
Figure 2018 North America mTOR Inhibitors Sales Market Share by Countries
Table North America mTOR Inhibitors Revenue by Countries (2014-2019) (Million US$)
Table North America mTOR Inhibitors Revenue Market Share by Countries (2014-2019)
Figure 2018 North America mTOR Inhibitors Revenue Market Share by Countries
Figure United States mTOR Inhibitors Sales Growth Rate (2014-2019) (K Units)
Figure United States mTOR Inhibitors Revenue Growth Rate (2014-2019) (K Units)
Figure Canada mTOR Inhibitors Sales Growth Rate (2014-2019) (K Units)
Figure Canada mTOR Inhibitors Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico mTOR Inhibitors Sales Growth Rate (2014-2019) (K Units)
Figure Mexico mTOR Inhibitors Revenue Growth Rate (2014-2019) (Million US$)
Table North America mTOR Inhibitors Sales by Product (2014-2019) (K Units)
Table North America mTOR Inhibitors Sales Market Share by Product (2014-2019)
Figure 2018 North America mTOR Inhibitors Market Share by Product
Table North America mTOR Inhibitors Sales by End User (2014-2019) (K Units)
Table North America mTOR Inhibitors Sales Market Share by End User (2014-2019)
Figure 2018 North America mTOR Inhibitors Market Share by End User
Figure Europe mTOR Inhibitors Sales Growth Rate 2014-2019 (K Units)
Figure Europe mTOR Inhibitors Revenue Growth Rate 2014-2019 (Million US$)
Table Europe mTOR Inhibitors Sales by Countries (2014-2019) (K Units)
Table Europe mTOR Inhibitors Sales Market Share by Countries (2014-2019)
Figure 2018 Europe mTOR Inhibitors Sales Market Share by Countries
Table Europe mTOR Inhibitors Revenue by Countries (2014-2019) (Million US$)
Table Europe mTOR Inhibitors Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe mTOR Inhibitors Revenue Market Share by Countries
Figure Germany mTOR Inhibitors Sales Growth Rate (2014-2019) (K Units)
Figure Germany mTOR Inhibitors Revenue Growth Rate (2014-2019) (Million US$)
Figure France mTOR Inhibitors Sales Growth Rate (2014-2019) (K Units)
Figure France mTOR Inhibitors Revenue Growth Rate (2014-2019) (Million US$)
Figure UK mTOR Inhibitors Sales Growth Rate (2014-2019) (K Units)
Figure UK mTOR Inhibitors Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy mTOR Inhibitors Sales Growth Rate (2014-2019) (K Units)
Figure Italy mTOR Inhibitors Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia mTOR Inhibitors Sales Growth Rate (2014-2019) (K Units)
Figure Russia mTOR Inhibitors Revenue Growth Rate (2014-2019) (Million US$)
Table Europe mTOR Inhibitors Sales by Product (2014-2019) (K Units)
Table Europe mTOR Inhibitors Sales Market Share by Product (2014-2019)
Figure 2018 Europe mTOR Inhibitors Market Share by Product
Table Europe mTOR Inhibitors Sales by End User (2014-2019) (K Units)
Table Europe mTOR Inhibitors Sales Market Share by End User (2014-2019)
Figure 2018 Europe mTOR Inhibitors Market Share by End User
Figure Asia Pacific mTOR Inhibitors Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific mTOR Inhibitors Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific mTOR Inhibitors Sales by Countries (2014-2019) (K Units)
Table Asia Pacific mTOR Inhibitors Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific mTOR Inhibitors Sales Market Share by Countries
Table Asia Pacific mTOR Inhibitors Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific mTOR Inhibitors Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific mTOR Inhibitors Revenue Market Share by Countries
Figure China mTOR Inhibitors Sales Growth Rate (2014-2019) (K Units)
Figure China mTOR Inhibitors Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan mTOR Inhibitors Sales Growth Rate (2014-2019) (K Units)
Figure Japan mTOR Inhibitors Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea mTOR Inhibitors Sales Growth Rate (2014-2019) (K Units)
Figure Korea mTOR Inhibitors Revenue Growth Rate (2014-2019) (Million US$)
Figure India mTOR Inhibitors Sales Growth Rate (2014-2019) (K Units)
Figure India mTOR Inhibitors Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia mTOR Inhibitors Sales Growth Rate (2014-2019) (K Units)
Figure Australia mTOR Inhibitors Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia mTOR Inhibitors Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia mTOR Inhibitors Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia mTOR Inhibitors Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia mTOR Inhibitors Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines mTOR Inhibitors Sales Growth Rate (2014-2019) (K Units)
Figure Philippines mTOR Inhibitors Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand mTOR Inhibitors Sales Growth Rate (2014-2019) (K Units)
Figure Thailand mTOR Inhibitors Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam mTOR Inhibitors Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam mTOR Inhibitors Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore mTOR Inhibitors Sales Growth Rate (2014-2019) (K Units)
Figure Singapore mTOR Inhibitors Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific mTOR Inhibitors Sales by Product (2014-2019) (K Units)
Table Asia Pacific mTOR Inhibitors Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific mTOR Inhibitors Market Share by Product
Table Asia Pacific mTOR Inhibitors Sales by End User (2014-2019) (K Units)
Table Asia Pacific mTOR Inhibitors Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific mTOR Inhibitors Market Share by End User
Figure Central & South America mTOR Inhibitors Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America mTOR Inhibitors Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America mTOR Inhibitors Sales by Countries (2014-2019) (K Units)
Table Central & South America mTOR Inhibitors Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America mTOR Inhibitors Sales Market Share by Countries
Table Central & South America mTOR Inhibitors Revenue by Countries (2014-2019) (Million US$)
Table Central & South America mTOR Inhibitors Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America mTOR Inhibitors Revenue Market Share by Countries
Figure Brazil mTOR Inhibitors Sales Growth Rate (2014-2019) (K Units)
Figure Brazil mTOR Inhibitors Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina mTOR Inhibitors Sales Growth Rate (2014-2019) (K Units)
Figure Argentina mTOR Inhibitors Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America mTOR Inhibitors Sales by Product (2014-2019) (K Units)
Table Central & South America mTOR Inhibitors Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America mTOR Inhibitors Market Share by Product
Table Central & South America mTOR Inhibitors Sales by End User (2014-2019) (K Units)
Table Central & South America mTOR Inhibitors Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America mTOR Inhibitors Market Share by End User
Figure Middle East and Africa mTOR Inhibitors Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa mTOR Inhibitors Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa mTOR Inhibitors Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa mTOR Inhibitors Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa mTOR Inhibitors Sales Market Share by Countries
Table Middle East and Africa mTOR Inhibitors Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa mTOR Inhibitors Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa mTOR Inhibitors Revenue Market Share by Countries
Figure GCC Countries mTOR Inhibitors Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries mTOR Inhibitors Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey mTOR Inhibitors Sales Growth Rate (2014-2019) (K Units)
Figure Turkey mTOR Inhibitors Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt mTOR Inhibitors Sales Growth Rate (2014-2019) (K Units)
Figure Egypt mTOR Inhibitors Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa mTOR Inhibitors Sales Growth Rate (2014-2019) (K Units)
Figure South Africa mTOR Inhibitors Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa mTOR Inhibitors Sales by Product (2014-2019) (K Units)
Table Middle East and Africa mTOR Inhibitors Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa mTOR Inhibitors Market Share by Product
Table Middle East and Africa mTOR Inhibitors Sales by End User (2014-2019) (K Units)
Table Middle East and Africa mTOR Inhibitors Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa mTOR Inhibitors Market Share by End User
Table LC Laboratories Company Details
Table LC Laboratories mTOR Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table LC Laboratories Recent Development
Table Teva Pharmaceutical Industries Ltd. Company Details
Table Teva Pharmaceutical Industries Ltd. mTOR Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Teva Pharmaceutical Industries Ltd. Recent Development
Table Exelixis Company Details
Table Exelixis mTOR Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Exelixis Recent Development
Table Novartis Oncology Company Details
Table Novartis Oncology mTOR Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Novartis Oncology Recent Development
Table Pfizer Company Details
Table Pfizer mTOR Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Pfizer Recent Development
Table GSK Company Details
Table GSK mTOR Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table GSK Recent Development
Table Global mTOR Inhibitors Sales Forecast by Regions 2019-2025 (K Units)
Table Global mTOR Inhibitors Sales Market Share Forecast by Regions 2019-2025
Table Global mTOR Inhibitors Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global mTOR Inhibitors Revenue Market Share Forecast by Regions 2019-2025
Table Global mTOR Inhibitors Sales Forecast by Product 2019-2025 (K Units)
Table Global mTOR Inhibitors Sales Market Share Forecast by Product 2019-2025
Table Global mTOR Inhibitors Revenue Forecast by Product 2019-2025 (Million US$)
Table Global mTOR Inhibitors Revenue Market Share Forecast by Product 2019-2025
Table Global mTOR Inhibitors Sales Forecast by End User 2019-2025 (K Units)
Table Global mTOR Inhibitors Sales Market Share Forecast by End User 2019-2025
Figure North America mTOR Inhibitors Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America mTOR Inhibitors Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe mTOR Inhibitors Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe mTOR Inhibitors Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific mTOR Inhibitors Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific mTOR Inhibitors Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America mTOR Inhibitors Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America mTOR Inhibitors Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa mTOR Inhibitors Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa mTOR Inhibitors Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table mTOR Inhibitors Value Chain
Table mTOR Inhibitors Customers List
Table mTOR Inhibitors Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
IDO阻害剤の世界市場：インサイト・予測 The IDO (indoleamine 2,3-dioxygenase 1, IDO1, IDO-1, INDO, indoleamine-pyrrole 2,3-dioxygenase) inhibitors pipeline analysis report includes ongoing clinical and non-clinical trends in the global IDO inhibitors market. Most of the pipeline therapeutics are in early stage of development, the market i…- 腎臓癌治療薬の世界市場：市場規模・現状・予測 Kidney Cancer Treatment Drugs are drugs used to cure kidney cancer.Market growth is largely driven by factors such as availability of novel drugs, presence of strong pipeline, and rise in incidence of renal cancer due to growing geriatric population and more prominent smoking habits. In 2018, the gl…
- TNF阻害剤の世界市場：市場規模・現状・予測 TNF (tumor necrosis factor) inhibitors are anti-inflammatory drugs. TNF inhibitors help to block the TNF alpha that occurs naturally in the body and causes inflammation. TNF drugs are used to reduce inflammation and stop disease progression by targeting the tumor necrosis factor, which is an inflamm…
- TNF阻害剤の世界市場：市場規模・現状・予測 TNF (tumor necrosis factor) inhibitors are anti-inflammatory drugs. TNF inhibitors help to block the TNF alpha that occurs naturally in the body and causes inflammation. TNF drugs are used to reduce inflammation and stop disease progression by targeting the tumor necrosis factor, which is an inflamm…
- 世界のイソクエン酸デヒドロゲナーゼ阻害剤市場：専門的調査 Isocitrate dehydrogenase (IDH) (EC 1.1.1.42) and (EC 1.1.1.41) is an enzyme that catalyzes the oxidative decarboxylation of isocitrate, producing alpha-ketoglutarate (α-ketoglutarate) and CO2.Specific mutations in the isocitrate dehydrogenase gene IDH1 have been found in several brain tumors includi…